Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

CorMedix Spikes To Four-Year High On A Surprise Deal For Its Leading Drug

CorMedix shares bounded to a four-year high Monday after the biotech company inked an expanded deal for its leading drug, DefenCath.

Investors Business Daily

Medical Services Name Flirts With A Buy Point

This medical services stock is in a cup-with-handle base. The biotech's tests detect cancer through blood tests.

Investors Business Daily

The FDA Shake-Up Continues, And Could Impact Genetic Medicines

The latest shake-up at the FDA forced out the top two officials in charge of reviewing cell and gene therapies, analysts said.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Purdue Pharma's $7B opioid settlement plan could get votes from victims and cities

A judge could decide Friday whether to advance OxyContin maker Purdue Pharma's $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids

The Independent UK

A judge could advance Purdue Pharma's $7B opioid settlement after all 50 states back it

A judge is being asked to clear the way for local governments and individual victims to vote on OxyContin maker Purdue Pharma’s plan to settle thousands of lawsuits over the toll of opioids

The Independent UK

FDA to offer faster drug reviews to companies promoting 'national priorities'

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump administration priorities for Americans' health

The Independent UK

Liver Drug Stock Rockets 236% Amid FDA Approval As Sales Accelerate; Funds Load Up

Biotech stock Mirum Pharmaceuticals has rocketed 236% since its IPO in 2019. Shares are near a buy point after earnings.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Purdue Pharma to pay $7.4 billion in opioid lawsuit settlement

Besides the hefty financial reward, the settlement also ends the Sackler family’s ownership of Purdue Pharma and their ability to sell opioids in the U.S.

The Independent UK

Second patient death reported with gene therapy for muscular dystrophy

Shares of Sarepta Therapeutics have plunged again after the drugmaker reported a second death in connection with its gene therapy for muscular dystrophy

The Independent UK

Purdue Pharma $7.4bn opioid settlement wins broad support from US states

The suit, brought by 55 attorneys general, will help compensate victims and fund addiction treatment programmes.

Al Jazeera

PPE from company linked to Mone did not meet required safety standards, court told

Department of Health wants refund of £122m spent on unused surgical gowns, but PPE Medpro says it went into contract with ‘eyes wide open’

The Guardian - UK

Suspected drug deaths in Scotland up by a third in three months, figures show

SUSPECTED drug deaths in Scotland have risen by a third in the first three months of this year, figures have revealed ...

The National (Scotland)

Top RFK Jr. aide attacks US health system while running company that promotes wellness alternatives

A top aide to Health Secretary Robert F

The Independent UK

Stocks With Rising Relative Strength: DexCom

A Relative Strength Rating upgrade for DexCom shows improving technical performance. Will it continue?

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Evening Standard

Rachel Reeves to announce £86bn for science and technology in spending review

Regions will be handed up to £500 million with local leaders given powers to decide how investment is targeted in their communities.

International Business Times UK

Can Birth Control Give You Brain Tumors? These 400 Women Say The Pfizer Shot Did

Hundreds of women allege Pfizer's contraceptive injection caused tumors, accusing the company of ignoring known dangers and insufficient safety warnings.

The Guardian - US

23andMe back on the auction block after former CEO makes 11th-hour bid

Anne Wojcicki, ex-CEO of the DNA testing firm, put in a $305m bid, upending Regeneron’s $256m agreement

Investors Business Daily

Cancer Stock Vaults 40% As Clinical Trial Shows 'Promise'; Sales Reach $1 Billion, Earnings To Triple

Cancer stock BeiGene renamed itself as BeOne. Shares have gained 40% year to date, outperforming the S&P 500.

Get all your
news in one place.

100’s of premium titles.
One news app.

Bored Panda

26 Examples Of Packaging So Misleading, It’s Basically A Scam, As Shared On This Online Community

These packages look like they were intentionally designed to lure away our money.

International Business Times

At No Cost to Federal Government a Lifeline for America's Communities

At its heart, 340B is about getting medicine—and the healthcare services needed to ensure their safe and effective use—to people who otherwise might go without it.

Evening Standard

Drug maker Indivior joins the flight from London share listings

Pharmaceuticals company said most of its product sales and shareholders are US based

Investors Business Daily

Funds Go All In On Weight-Loss Leader; Stock Nears Highs

Rhythm stock is approaching its all-time high in a long base. Rhythm makes drugs to treat disorders due to genetic changes.

Investors Business Daily

Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly

Novo Nordisk is rapidly ceding market share to Eli Lilly. And the paradigm shift is showing up in Novo Nordisk stock.

Investors Business Daily

How Boston Scientific's Surprise Setback Bolstered Two Of Its Top Rivals

Edwards Lifesciences stock jumped Wednesday after Boston Scientific said it would stop selling its rival heart-valve replacement systems.

The Independent UK

New ‘superbug’ antibiotic to treat sepsis and pneumonia enters last phase of testing

It is hoped that the drug zosurabalpin will be approved by the end of the decade

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Scottish Government

Investor Business Daily

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.